Importantly, in recurrent mammary tumors, the quantities of CD4(+)/CD25(+)/CD127(−) regulatory T cells (Tregs) present were significantly diminished following postsurgical treatment with olaparib and/or Oligo-Fucoidan (Fig. 7C). Here, CD4 is linked to breast cancer.